Clinical Trial

Evaluation of Effect of Scatter on Visual Performance

Completed
View on ClinicalTrials.gov →
Summary
This will be a 3-visit, single-site, randomized, single-masked, bilateral wear, non-dispensing, crossover study which will evaluate visual performance with different magnitudes of scatter.
Protocol Amendment History 2 changes
critical Trial completed 2026-06-10
notable Enrollment reduced: 36 -> 31 participants 2026-06-10
Trial Details
NCT Number NCT07443215
Lead Sponsor Johnson & Johnson Vision Care, Inc.
Conditions Visual Acuity
Enrollment 31 participants
Start Date 2026-02-13
Primary Completion 2026-05-22 (estimated)
Study Completion 2026-05-22 (estimated)
Updated on ClinicalTrials.gov 2026-06-09